TimesSquare Capital Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-18,850
Closed -$3.08M 263
2017
Q4
$3.08M Sell
18,850
-254
-1% -$45.6K 0.02% 236
2017
Q3
$3.92M Buy
19,104
+155
+0.8% +$36K 0.03% 239
2017
Q2
$4.61M Sell
18,949
-1,615
-8% -$380K 0.03% 239
2017
Q1
$4.91M Sell
20,564
-1,050
-5% -$245K 0.03% 234
2016
Q4
$4.54M Sell
21,614
-1,990
-8% -$412K 0.03% 230
2016
Q3
$5.44M Sell
23,604
-960
-4% -$235K 0.04% 235
2016
Q2
$5.68M Sell
24,564
-5,295
-18% -$1.22M 0.04% 227
2016
Q1
$8M Sell
29,859
-140
-0.5% -$40.1K 0.05% 217
2015
Q4
$9.38M Sell
29,999
-1,930
-6% -$575K 0.06% 218
2015
Q3
$8.68M Sell
31,929
-2,265
-7% -$696K 0.05% 223
2015
Q2
$10.4M Sell
34,194
-2,541
-7% -$758K 0.06% 227
2015
Q1
$10.9M Sell
36,735
-3,945
-10% -$1.12M 0.06% 228
2014
Q4
$10.5M Sell
40,680
-885
-2% -$221K 0.06% 221
2014
Q3
$10M Sell
41,565
-2,646
-6% -$592K 0.06% 224
2014
Q2
$9.86M Sell
44,211
-2,352
-5% -$487K 0.05% 224
2014
Q1
$9.59M Sell
46,563
-6,261
-12% -$1.24M 0.05% 226
2013
Q4
$8.87M Buy
+52,824
New +$8.26M 0.04% 224

Other funds holding AGN

TimesSquare Capital Management's AGN Position: Q1 2018 in Review

TimesSquare Capital Management sold out of Allergan plc (AGN) in Q1 2018, closing a stake of 18,850 shares — an estimated $3.08M sold.

TimesSquare Capital Management first reported a position in AGN in Q4 2013 and held it in 17 quarters. The position peaked at $10.9M in Q1 2015. 1,022 funds tracked by Wall St. Rank hold AGN as of Q1 2018.

  • TimesSquare Capital Management reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
  • TimesSquare Capital Management sold 18,850 Allergan plc shares in Q1 2018, an estimated $3.08M.
  • TimesSquare Capital Management first reported a position in Allergan plc in Q4 2013 and held it in 17 quarters.
  • TimesSquare Capital Management's Allergan plc position peaked at $10.9M in Q1 2015.
  • 1,022 funds tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on TimesSquare Capital Management's 13F filing for Q1 2018, filed 15 May 2018.